Exchange: OTC·Updated 12:06 PM EDT

About IRLAF

About

IRLAB Therapeutics AB engages in the provision of novel treatments for disorders of the brain that focuses on illness in the central nervous system. The fim develops drugs for Parkinson's disease. It also offers IRL752 that targets dementia in Parkinson's disease. The company was founded in 2013 and is headquartered in Gothenburg, Sweden.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is the 52-week high for IRLAB Therapeutics AB - Ordinary Shares - Class A?
What is the 52-week low for IRLAB Therapeutics AB - Ordinary Shares - Class A?
What is IRLAB Therapeutics AB - Ordinary Shares - Class A stock price today?
What is the 50-day moving average of IRLAB Therapeutics AB - Ordinary Shares - Class A?

Advertisement|Remove ads.